Related Experiment Video
Updated: Feb 22, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Evaluation of PE_PGRS33 as a potential surface target for humoral responses against Mycobacterium tuberculosis
Mariachiara Minerva1, Flavio De Maio1, Serena Camassa1
1Institute of Microbiology, Università Cattolica del Sacro Cuore - Fondazione Policlinico Universitario Gemelli, 00168 Rome, Italy.
Abstract:
Mycobacterium tuberculosis (Mtb) PE_PGRS33 is a surface-exposed protein that was shown to interact with Toll-like receptor 2 on host macrophages to induce inflammatory signals and promote entry in macrophages. In this study, we investigated PE_PGRS33 as a potential target of a humoral response aimed at hampering key processes in tuberculosis pathogenesis. PE_PGRS33 protein was successfully expressed and purified under native condition in Escherichia coli. The purified protein retained its native functional and biological properties, showing the ability to elicit proinflammatory signals in murine and human macrophages. Interestingly, a polyclonal antiserum raised against native PE_PGRS33 showed no cross-reactions with other mycobacterial proteins. The anti-PE_PGRS33 serum was also able to inhibit Mtb entry into macrophages, but it did not reduce entry of the MtbΔpe_pgrs33 strain. Addition of native recombinant PE_PGRS33 to the MtbΔpe_pgrs33 strain during infection restored the Mtb wild-type entry phenotype in macrophage. Moreover, the anti-PE_PGRS33 serum was able to neutralize the proinflammatory activity of PE_PGRS33 in vitro. Furthermore, mice immunized with native recombinant PE_PGRS33, but not with a DNA vaccine expressing PE_PGRS33, were able to restrict M. smegmatis in vivo. These results highlight the potential use of PE_PGRS33 as a target of a neutralizing humoral response against tuberculosis.
Insights
Targeting Mycobacterium tuberculosis PE_PGRS33 with antibodies can block bacterial entry into macrophages and reduce inflammation. This study shows PE_PGRS33 is a promising target for tuberculosis humoral response therapies.
Area of Science:
- Immunology
- Microbiology
- Molecular Biology
Background:
- Mycobacterium tuberculosis (Mtb) PE_PGRS33 is a surface protein.
- It interacts with Toll-like receptor 2 on macrophages, inducing inflammation and promoting Mtb entry.
Purpose of the Study:
- Investigate PE_PGRS33 as a target for humoral immune response.
- Aim to hinder key tuberculosis pathogenesis processes.
Main Methods:
- Expressed and purified native PE_PGRS33 protein in E. coli.
- Raised polyclonal antiserum against native PE_PGRS33.
- Tested antiserum's effect on Mtb entry, inflammation, and in vivo M. smegmatis restriction.
Main Results:
- Purified PE_PGRS33 elicited proinflammatory signals in macrophages.
- Anti-PE_PGRS33 serum inhibited Mtb entry and neutralized PE_PGRS33's proinflammatory activity.
- Mice immunized with native PE_PGRS33 restricted M. smegmatis in vivo.
Conclusions:
- PE_PGRS33 is a potential target for a neutralizing humoral response against tuberculosis.
- Antibodies against PE_PGRS33 can block Mtb pathogenesis.
- Native recombinant PE_PGRS33 vaccination shows in vivo efficacy.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016